Why CPRX? Catalyst Pharmaceuticals, Inc. Analysis, Price & AI Insights | Whystock
CPRX
$28.74+0.61 (+2.17%)
Market ClosedLast close May 1
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.